Literature DB >> 4809459

Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells.

E M Hersh, B Drewinko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4809459

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

1.  Disparity in the production of lymphoblastogenesis inhibition factor by cultured human B and T lymphoid cell lines.

Authors:  T Han; J L Pauly; J Minowada
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.

Authors:  S Agrawal; J Marquet; M H Delfau-Larue; C Copie-Bergman; H Jouault; F Reyes; A Bensussan; J P Farcet
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

3.  Inhibition or augmentation of PHA-induced lymphocyte transformation by factors of calculated lymphoblastoid cell lines.

Authors:  M Pinto; A Mizrahi
Journal:  Experientia       Date:  1979-04-15

4.  Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.

Authors:  E M Hersh; K B McCredie; E J Freireich
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

Review 5.  [Humoral factors in the regulation of cell proliferation in haematopoiesis. I. Granulopoiesis and lymphopoiesis (author's transl)].

Authors:  E Heidemann
Journal:  Klin Wochenschr       Date:  1980-10-15

6.  Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells.

Authors:  A Keong; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro.

Authors:  J Werkmeister; R Zbroja; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

8.  Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein.

Authors:  N Hanna; R Kalderon; D Nelken
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

9.  Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell line.

Authors:  J J Lightbody; W D Peterson; M D Poulik
Journal:  In Vitro       Date:  1978-05

10.  Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.

Authors:  B Sheid; J Boyce
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.